Episode Details

Executive Summary This report provides a comprehensive investment analysis of BioGaia AB publ (BIOG-B.ST), a Swedish healthcare company specializing in the development and commercialization of clinically-validated probiotic products. The company has established a global leadership position in its niche, founded upon a deep scientific moat built around its proprietary strains of the lactic acid bacterium, […]